A large, prospective study implicates high levels of interleukin 6 with severity of diabetic retinopathy and shows it may be ...

The FDA issued a complete response letter to Genentech indicating it cannot approve the company’s biologic license ...

Biotechnology and biomedical engineering are distinct yet impactful fields shaping healthcare's future. Biotechnology delves ...

Intravitreal ceftazidime may help treat syphilitic uveitis when IV penicillin is delayed. A case series reported that 14 eyes ...

Genentech, part of the Roche Group ( OTCQX:RHHBY) ( OTCQX:RHHBF) ( OTCPK:RHHVF ), announced that the U.S. FDA has rejected ...

Here's what lies ahead Drug giant promises $50 billion U.S. investment Drug giant promises $50 billion U.S. investment Bay ...

The FDA has declined to approve Columvi, in combination with the chemo regimen GemOx, for the treatment of second-line DLBCL ...

New data shows which companies are hiring the most UC alumni, and what kinds of jobs they are getting hired for. The UC ...

North Carolina’s economy continues to outpace that of most competitors. The latest employment report from the U.S. Bureau of ...

Harrow has entered into an agreement with Samsung Bioepis for the U.S. commercial rights to two ophthalmology biosimilars, ...

Genentech is planning a massive overhaul of its 207-acre South San Francisco campus that could cost between $3B and $5B by the time the multiphase project is complete, according to the San Francisco ...

Seven biotech unicorns are advancing AI-powered drug discovery and development—but must contend with a difficult investing ...